SARS-CoV-2 seroprevalence in oncology healthcare professionals and patients with cancer at a tertiary care centre during the COVID-19 pandemic

SARS-CoV-2 seroprevalence in oncology healthcare professionals and patients with cancer at a tertiary care centre during the COVID-19 pandemic

Background During the COVID-19 outbreak, healthcare professionals (HCP) are at the frontline of clinical management and at increased risk for infection. The SARS-CoV-2 seroprevalence of oncological HCP and their patients has significant implications for oncological care.Methods HCP and patients with...

Full description

Bibliographic Details
Main Authors: Matthias Preusser, Hannah Christina Puhr, Anna Sophie Berghoff, Thorsten Fuereder, Florian Moik, Gerwin Heller, Helmuth Haslacher, Thomas Perkmann, Robert Strassl, Julia Maria Berger, Judith Kreminger, Lorenz Schubert, Angelika Martina Starzer, Ariane Steindl, Stefan Winkler, Selma Tobudic
Format: Article
Language:English
Published: Elsevier 2020-10-01
Series:ESMO Open
Online Access:https://esmoopen.bmj.com/content/5/5/e000889.full

Internet

https://esmoopen.bmj.com/content/5/5/e000889.full

Similar Items